Avecho Biotechnology Limited (ASX:AVE) Share Market Overview and Biotechnology Sector Profile

Anjali Anand

11 August 2026 11:19 PM AEST

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

Avecho Biotechnology Limited (ASX:AVE) shares traded at $0.021 during the latest trading session.
The company recorded a daily share price movement of -4.545%, with trading Volume of 538,373 shares.
Avecho Biotechnology Limited recorded a Market Capitalisation of $85.00M.
The stock traded within a daily range of $0.021 to $0.022.
AVE shares recorded a 52-week trading range between $0.004 and $0.027.

Avecho Biotechnology Limited (ASX:AVE) Market Overview

Avecho Biotechnology Limited (ASX:AVE) is an Australian Securities Exchange-listed company operating within the pharmaceuticals, biotechnology and life sciences industry group.

The company’s shares were trading at $0.021, with a daily movement of -4.545%. This article provides an educational overview of Avecho Biotechnology’s market information, including share price activity, trading volume, market capitalisation and key share statistics.

Share Price Movement and Trading Activity

Avecho Biotechnology Limited recorded a share price of $0.021 during the latest trading session, compared with the previous close of $0.022. The stock declined by $0.001, representing a daily movement of -4.545%.

During the session, AVE shares traded within a range of $0.021 to $0.022. The company recorded trading volume of 538,373 shares, while the average trading volume was 12,117,349 shares.

Trading volume reflects the number of shares exchanged during a Trading session and is commonly considered alongside share price changes to understand market participation.

Market Capitalisation and Share Information

Avecho Biotechnology Limited recorded a market capitalisation of $85.00M. Market capitalisation represents the total Market Value of a listed company based on its share price and shares outstanding.

The company has 3,863,725,873 shares on issue, with ordinary fully paid shares listed on the Australian Securities Exchange.

The company’s International Securities Identification Number (ISIN) is AU0000047441.

Historical Trading Range

Avecho Biotechnology Limited shares recorded a 52-week trading range between $0.004 and $0.027.

The 52-week range provides a historical reference of the highest and lowest prices recorded by the stock over the previous year. It is commonly used to review changes in share price levels over different market conditions.

The movement of a stock within its historical range reflects market activity over time and may be influenced by company updates, sector conditions and broader market factors.

Pharmaceuticals, Biotechnology and Life Sciences Sector

Avecho Biotechnology Limited is classified within the pharmaceuticals, biotechnology and life sciences industry group. This sector includes companies involved in the research, development and commercial activities associated with healthcare-related technologies and products.

Companies operating in this sector may experience changes in market activity due to factors such as research progress, regulatory developments, industry conditions and broader investor participation.

For listed biotechnology companies, Market Indicators such as share price movements, trading volume and market capitalisation are commonly reviewed alongside company disclosures.

Listing History and Market Information

Avecho Biotechnology Limited was listed on the Australian Securities Exchange on 9 August 1993.

The company’s ordinary fully paid shares trade under the ticker code ASX:AVE. Its market profile includes daily price movements, trading activity, historical price range and market capitalisation.

These indicators provide an overview of the company’s position within the listed Equity market and allow Market Participants to track changes in trading patterns.

Understanding ASX Biotechnology Stocks

Biotechnology companies listed on the Australian Securities Exchange often operate within research-driven industries where market activity can be influenced by developments in healthcare innovation, regulatory processes and company announcements.

Share price, trading volume and market capitalisation are among the commonly monitored indicators when reviewing listed companies. However, these market metrics represent trading activity and do not provide a complete assessment of Business operations or financial performance.

Company reports, official announcements and financial disclosures provide additional information about business activities and developments.

Conclusion

Avecho Biotechnology Limited (ASX:AVE) recorded a share price of $0.021, with a daily movement of -4.545% and trading volume of 538,373 shares. The company recorded a market capitalisation of $85.00M and operates within the pharmaceuticals, biotechnology and life sciences industry group. With a 52-week trading range of $0.004 to $0.027, AVE’s market activity reflects movements in its listed shares within the Australian equity market. This article provides an educational overview of available market information and does not constitute financial advice or Investment recommendations.

FAQs

Q: What is the ASX ticker code for Avecho Biotechnology Limited?

A:Avecho Biotechnology Limited is listed on the Australian Securities Exchange under the ticker code ASX:AVE.

Q: What was Avecho Biotechnology Limited’s latest share price?

A:Avecho Biotechnology Limited shares were trading at $0.021.

Q: What was the daily share price movement for ASX:AVE?

A:The company recorded a daily share price movement of -4.545%.

Q: What is Avecho Biotechnology Limited’s market capitalisation?

A:Avecho Biotechnology Limited recorded a market capitalisation of $85.00M.

Q: Which industry group does Avecho Biotechnology Limited belong to?

A:Avecho Biotechnology Limited belongs to the pharmaceuticals, biotechnology and life sciences industry group.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.